GloveOn Maverick LC is a worthy addition to the Maverick family. The all-rounder glove is thicker with an extended cuff length to suit situations which require greater protection.
| Reorder Code | Size |
|---|---|
| NTR26XS | X-Small |
| NTR26XXL | XX-Large |
Maverick LC Nitrile Exam Gloves Long Cuff
View Product
> Fingertip textured
> Powder Free
> Not made with natural rubber latex
> Chemo drugs tested
> Ambidextrous
> Long Cuff
> Aqua blue colour
| Glove Properties | Measurement (mm) |
|---|---|
| Length | 290 ± 10 |
| Thickness at Palm (centre of Palm) | 0.09 ± 0.02 |
| Thickness at Finger (13mm ± 3mm from tip) | 0.14 ± 0.02 |
| Physical Properties | Before Ageing | After Ageing |
|---|---|---|
| Tensile Strength (MPa) | ≥18 | ≥16 |
| Elongation (%) | ≥500 | ≥500 |
| Elongation after Isopropanol immersion (%) | ≥500 | N/A |
| Inspection Levels and AQL | Inspection Level | AQL |
|---|---|---|
| Watertightness | G1 | 1.5 |
| Physical Dimensions | S2 | 4.0 |
| Tensile Strength | S2 | 4.0 |
| Visual Inspection (Major) | S4 | 2.5 |
| Visual Inspection (Minor) | S4 | 4.0 |
| Particulate Residue | N=5 | ≤2mg/glove |
| Packaging | |
|---|---|
| Configuration | 100 gloves per box for XS to XL 80 gloves per box for XXL 10 boxes per carton |
| Regulatory Compliance | |
|---|---|
| Regulations | ARTG 164563 FDA 510(k) MDR 2017/745 REACH ROHS Directive 2011/65/EU EU 10/2011 EC 1935/2004 EU 2016/425 |
| International Standards | |
|---|---|
| Standards | ASTM D6319 ASTM D5151 ASTM D6124 ASTM D6978 EN ISO 374-1 (Type B) EN 16523-1 EN 374 part 2, 4 & 5 EN 420 EN 455 part 1, 2, 3 & 4 EN 1186 EN 13130 CEN/TS 14234 NFPA 1999 ISO 10993 part 5 & 10 HACCP International Certified |
| Manufacturing Accreditations | |
|---|---|
| Accreditations | ISO 9001 ISO 13485 EN ISO 13485 |
| Chemotherapy Drugs and Concentration (Tested for Resistance to Permeation by Chemotherapy Drugs as per ASTM D6978-05, Test Report PN 101567) | Minimum Breakthrough Detection Time (minutes) |
|---|---|
| Carmustine (BCNU), 3.3mg/ml (3,300ppm) | 15.1 |
| Cisplatin, 1.0mg/ml (1,000ppm) | >240 |
| Cyclophosphamide (Cytoxan), 20.0mg/ml (20,000ppm) | >240 |
| Dacarbazine (DTIC), 10.0mg/ml (10,000ppm) | >240 |
| Doxorubicin Hydrochloride, 2.0mg/ml (2,000ppm) | >240 |
| Etoposide (Toposar), 20.0mg/ml (20,000ppm) | >240 |
| Fluorouracil, 50.0mg/ml (50,000ppm) | >240 |
| Methotrexate, 25.0mg/ml (25,000ppm) | >240 |
| Mitomycin C, 0.5mg/ml (500ppm) | >240 |
| Paclitaxel (Taxol), 6.0mg/ml (6,000ppm) | >240 |
| Thiotepa, 10.0mg/ml (10,000ppm) | 30.8 |
| Vincristine Sulfate, 1.0mg/ml (1,000ppm) | >240 |
| WARNING: Carmustine and Thiotepa, at the tested concentration, degraded a Maverick LC nitrile glove at 15.1 minutes and 30.8 minutes respectively. The safe use of gloves in chemotherapy treatment is solely the decision of clinicians authorised to make such a decision. | |
FEATURED SELLERS
